These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines. Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345 [TBL] [Abstract][Full Text] [Related]
8. Potential radiosensitizing agents. 6. 2-Nitroimidazole nucleosides: arabinofuranosyl and hexopyranosyl analogues. Sakaguchi M; Larroquette CA; Agrawal KC J Med Chem; 1983 Jan; 26(1):20-4. PubMed ID: 6827525 [TBL] [Abstract][Full Text] [Related]
9. Dual-function radiosensitizers. Alpha-[[(2-bromoethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol and related compounds: preparation via an aziridine equivalent. Suto MJ; Stier MA; Werbel LM J Med Chem; 1991 Mar; 34(3):1207-9. PubMed ID: 2002462 [TBL] [Abstract][Full Text] [Related]
10. Nitroimidazoles, XIV: Synthesis of 4-nitroimidazoles with 1-substituents containing acid, ester or phenol functions, and radiosensitizing efficiency of some of these compounds. Suwinski J; Szczepankiewicz W; Widel M Arch Pharm (Weinheim); 1992 Jun; 325(6):317-24. PubMed ID: 1444756 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties. Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716 [TBL] [Abstract][Full Text] [Related]
13. A comparative study on the radiosensitizing effects and cytotoxic properties of misonidazole and 2,4-dinitroimidazole-1-ethanol in HeLa S3 cells. Murayama C; Hori H; Inayama S; Mori T Gan; 1982 Aug; 73(4):588-91. PubMed ID: 7152197 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility. Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125 [TBL] [Abstract][Full Text] [Related]
15. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro. Zhou L; Nishimoto S Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282 [TBL] [Abstract][Full Text] [Related]
17. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents]. Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567 [TBL] [Abstract][Full Text] [Related]
18. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells]. Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers. Papadopoulou MV; Rosenzweig HS; Bloomer WD Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395 [TBL] [Abstract][Full Text] [Related]
20. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin. Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]